Ambrx Biopharma Inc Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ambrx Biopharma Inc   (NASDAQ: AMAM)

AMAM's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021


Y / Y Equity Change -37.96 % - - - -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

AMAM all Ratios >> Back to AMAM Management Effectiveness >> See Quarterly AMAM Return On Equity

You need to upgrade your Flash Player


Financial Statements
Ambrx Biopharma Inc 's Equity $ 118 Millions Annual AMAM's Balance sheet
Ambrx Biopharma Inc 's Annual Income $ -78 Millions Annual AMAM's Income Statement
Where are AMAM's Income coming from? Visit AMAM's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.